The Singapore Immunology Network (SIgN) is a research consortium established in 2006 under the Agency for Science, Technology and Research (A*STAR)’s Biomedical Research Council. The mission of SIgN is to advance human translational immunology research, contribute scientific knowledge and make innovative discoveries in immune-based therapeutics and technologies so as to improve lives and further socio-economic growth. SIgN is home to ~150 researchers comprising renowned Principal Investigators, post-doctoral fellows and support staff working under the directorship of Professor Lam Kong Peng. SIgN also contributes to nurturing and retaining research talents to help build up the research ecosystem in Singapore. SIgN research activities are broadly categorised into three main focus areas: Immuno-Oncology, Immune Potential, Regulation & Ageing and Immuno-Pathology. Our research groups are supported by a strong in-house cluster of cutting-edge technology platforms. Through partnership with hospitals and companies, SIgN is also committed to translate research findings into clinical and commercial applications. SIgN is working towards contributing to an enriching and vibrant research environment in Singapore.
Visit SIgN Website
Please select your background to explore relevant equipment & services
